International edition Finance & trade

Tuesday, 3 November 2026

National Trade News

Independent coverage of global markets, trade and finance

Home / Finance & markets

Finance & markets

Friday 10/9 Insider Buying Report: IMMR, PHK

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

Nasdaq 100 Movers: TMUS, HONIV

In early trading on Friday, shares of Honeywell International topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.5%. Year to date, Honeywell International registers a 42.2% gai…

YieldBoost CVR Energy From 0.7% To 16.4% Using Options

Shareholders of CVR Energy Inc (Symbol: CVI) looking to boost their income beyond the stock's 0.7% annualized dividend yield can sell the March 2027 covered call at the $80 strike and collect the premium based on the $4…

Why is LG Energy Solution stock surging today?

Ford Motor Company (F) stock surged 36% in May 2026 following its strategic pivot into grid-scale energy storage, with the centerpiece being a five-year framework agreement with EDF Power Solutions North America valued …

Delta stock slides on Q3 profit miss, full-year outlook cut

Delta Air Lines (DAL) delivered record third-quarter revenue yet slashed its full-year earnings outlook by nearly a quarter, a stark illustration of how the surge in energy prices since February is overwhelming the carr…

A Potential S&P 500 Double Top Meets Rising Credit Stress

S&P 500 finished the day lower but remains above the 10-day exponential moving average, so nothing material has changed for the index at this point. A break below that average could signal a shift in the recent trend an…

Wheat Sees Weakness Ahead of USDA Report

Grain futures higher overnight ahead of WASDE… At 6:00 a.m. CDT, December corn was up 4 3/4 cents. November soybeans were 5 3/4 cents higher. September soybean meal was up $2.70. September bean oil was 3 points lower. S…

ADARx Pharmaceuticals prices upsized IPO at $17 per share

A San Diego biotech betting on RNA-based medicine is asking Wall Street for a valuation of up to $1.74 billion as it heads toward a Nasdaq debut. ADARx Pharmaceuticals plans to offer 21.9 million shares priced between $…